<bill session="116" type="s" number="1617" updated="2019-09-18T05:12:26Z">
  <state datetime="2019-05-22">REFERRED</state>
  <status>
    <introduced datetime="2019-05-22"/>
  </status>
  <introduced datetime="2019-05-22"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the listing of patents in the Orange Book.</title>
    <title type="short" as="introduced">Second Look at Drug Patents Act of 2019</title>
    <title type="short" as="introduced">Second Look at Drug Patents Act of 2019</title>
    <title type="display">Second Look at Drug Patents Act of 2019</title>
  </titles>
  <sponsor bioguide_id="M001111"/>
  <cosponsors>
    <cosponsor bioguide_id="C001056" joined="2019-05-22"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-22" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Intellectual property"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
